PFG Advisors
AZN icon

PFG Advisors’s AstraZeneca AZN Stock Holding History

PFG Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,713
Closed -$325K – 764
2026
Q2 		$325K Sell
1,713
-127
-7% -$23.9K 0.02% 642
2026
Q1 		$363K Sell
1,840
-277
-13% -$53.4K 0.02% 615
2025
Q4 		$389K Sell
2,117
-748
-26% -$131K 0.02% 577
2025
Q3 		$440K Buy
2,865
+441
+18% +$66.7K 0.02% 587
2025
Q2 		$339K Buy
+2,424
New +$340K 0.02% 497

Other funds holding AZN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $162B AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

PFG Advisors's AZN Position: Q3 2026 in Review

PFG Advisors sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,713 shares — an estimated $325K sold.

PFG Advisors first reported a position in AZN in Q2 2025 and held it in 5 quarters. The position peaked at $440K in Q3 2025. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • PFG Advisors reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
  • PFG Advisors sold 1,713 AstraZeneca shares in Q3 2026, an estimated $325K.
  • PFG Advisors first reported a position in AstraZeneca in Q2 2025 and held it in 5 quarters.
  • PFG Advisors's AstraZeneca position peaked at $440K in Q3 2025.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.